- Home
- HUIZ vs RFL Comparison
HUIZ vs RFL Comparison
Compare HUIZ & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- RFL
- Stock Information
- Founded
- HUIZ 2006
- RFL 2017
- Country
- HUIZ China
- RFL United States
- Employees
- HUIZ N/A
- RFL N/A
- Industry
- HUIZ Specialty Insurers
- RFL Real Estate
- Sector
- HUIZ Finance
- RFL Finance
- Exchange
- HUIZ Nasdaq
- RFL Nasdaq
- Market Cap
- HUIZ 41.7M
- RFL 48.4M
- IPO Year
- HUIZ 2020
- RFL N/A
- Fundamental
- Price
- HUIZ $0.67
- RFL $2.02
- Analyst Decision
- HUIZ
- RFL
- Analyst Count
- HUIZ 0
- RFL 0
- Target Price
- HUIZ N/A
- RFL N/A
- AVG Volume (30 Days)
- HUIZ 16.1K
- RFL 23.5K
- Earning Date
- HUIZ 12-03-2024
- RFL 12-12-2024
- Dividend Yield
- HUIZ N/A
- RFL N/A
- EPS Growth
- HUIZ N/A
- RFL N/A
- EPS
- HUIZ 0.06
- RFL N/A
- Revenue
- HUIZ $154,359,355.00
- RFL $637,000.00
- Revenue This Year
- HUIZ N/A
- RFL N/A
- Revenue Next Year
- HUIZ $10.46
- RFL N/A
- P/E Ratio
- HUIZ $11.36
- RFL N/A
- Revenue Growth
- HUIZ N/A
- RFL 128.32
- 52 Week Low
- HUIZ $0.43
- RFL $1.29
- 52 Week High
- HUIZ $1.08
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- HUIZ 36.94
- RFL 59.29
- Support Level
- HUIZ $0.68
- RFL $1.74
- Resistance Level
- HUIZ $0.77
- RFL $1.96
- Average True Range (ATR)
- HUIZ 0.05
- RFL 0.10
- MACD
- HUIZ -0.01
- RFL 0.01
- Stochastic Oscillator
- HUIZ 0.06
- RFL 94.83
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.